Follow the Integrum AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Integrum AB has published 12 public disclosures. Market capitalisation: €234.1m. The latest transaction was reported on 8 July 2026 (Purchase). Among the most active insiders: Kristofer Westergren. Every trade is accessible without an account.
12
Insider Decl.
n/a
Thresholds
€700,106
8 ops.
Buy Volume
n/a
2 ops.
Sell Volume
32Σ signal
Buys €700,106n/a Sells
Fundamental score
Ranked 26,280 of 29,063 companies
21.4
score / 100
Value
10
Quality
33
FCF yld-25%
Earn yld-20%
EV/EBITDA·
ROE-27%
Gross mgn69%
Net mgn-51%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Integrum AB es una empresa del sector de la salud y farmacéutico, enfocada en el desarrollo de soluciones innovadoras para la atención médica. Cotiza en la bolsa XSTO.